Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q3 2007
Executive Summary
In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for July-September 2007. Our data are derived from Windhover's Strategic Transactions Database.
You may also be interested in...
Start-Up Quarterly Statistics, Q4 2007
Start-Up analyzes fundraising and alliances among start-ups in the biopharmaceutical, medical device and in vitro diagnostics segments from October through December 2007. Data is derived from Windhover’s Strategic Transactions Database.
Medco: Market Multiplier for Personalized Medicine
Medco is developing data that could accelerate the adoption of personalized medicine--as a way to make itself more relevant to customers and the lives they represent. Armed with infrastructure from its mail pharmacy business and access to medical information on large groups of people, it is financing and conducting studies to show the value of pharmacogenomic tests in improving clinical outcomes. By so doing, it could become an incredible enabler of companies pursuing personalized medicine.
JenaValve Technology GMBH
JenaValve is developing percutaneous aortic valve replacement technology for high-risk patients with severe aortic stenosis. Its self-expanding heart valve and delivery system offer flexible conduit and secure implantation under beating-heart conditions, and its stent valve positioning system has the unique ability to reposition at any time, which is important for precise placement of the implant.